Bristol-Myers’ newly approved schizophrenia treatment might be coming full circle.

Scientists believe they've discovered where the "voices" heard by some schizophrenic people emanate from using brainwave ...

Many researchers believe that schizophrenia can affect a person's ability to smell and how they perceive smells. However, the ...

Popular depictions of schizophrenia often focus on visual hallucinations, but auditory hallucinations are far more common. At ...

Off the scrapheap of discarded drugs and on its way to becoming the most highly anticipated approval of 2024, Bristol Myers ...

The U.S. Food and Drug Administration (FDA) on Thursday approved the first new drug to treat people with schizophrenia in ...

Researchers observed a bidirectional, causal relationship between gut microbiome and schizophrenia in a Mendelian randomization analysis.

Researchers identified that impaired corollary discharge (CD) and noisy efference copy (EC) in schizophrenia disrupt ...

Scientists now have greater insight into one of Schizophrenia's poorly understood hallmarks — auditory hallucinations.

For the first time in nearly 30 years, the U.S. Food and Drug Administration has approved a new drug treating schizophrenia, ...

Adults with schizophrenia spectrum disorders have high rates of comorbid mental health and substance use disorders, according ...

On Thursday, the U.S. Food and Drug Administration approved COBENFY, an oral medication that marks the first new class of ...